(Q37532496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Vicki L Ellingrod

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

1 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

822-831

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558256%20AND%20SRC:MED&resulttype=core&format=json

The pharmacogenomics of selective serotonin reuptake inhibitors.

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Pharmacogenetics of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822

Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.822